Supply Chain

  1. An Inside Look At Umoja Biopharma And Bristol Myers Squibb's Cold Chains 11/13/2023

    Umoja's Co-Founder and CTO Ryan Crisman details The CLIMB and how an optimized cold chain is critical in the work being done there. Rookie Gleich, Global Head, Cell Therapy Logistics and Shipping Systems, BMS explains some of the cell therapy temperature standardization and why a wider temperature range may optimize the process.

  2. Balancing Innovation With Manufacturability When GMP-Grade Is Unavailable 12/4/2025

    Some raw materials simply aren't available in GMP. Experts Yan Zhi and Lawrence Thompson describe risk assessment approaches that inform sourcing decisions in this segment from Cell & Gene Live "Viability On The Line." Some investigational therapies require many unique raw materials, and controlling them appropriately gets tricky. Complexities also vary by modality and batch size. Control strategies must be adaptable.